NYXOAH SA - ORDINARY SHARES
9.8200
13-March-25 04:32:09
15 minutes delayed
Stocks
+0.7000
+7.68%
Today's range
9.8200 - 9.8200
ISIN
BE0974358906
Source
Cboe
-
Information on the Total Number of Voting Rights and Shares
30 Aug 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
08 Aug 2023 16:05:00 By Nasdaq GlobeNewswire
-
Publication Relating to a Transparency Notification
27 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference
27 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023
27 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Information on the Total Number of Voting Rights and Shares
27 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah Reports First Quarter 2023 Financial and Operating Results
16 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023
12 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
10 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023
01 May 2023 16:30:00 By Nasdaq GlobeNewswire
-
Publication Relating to Transparency Notifications
20 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
Information on the Total Number of Voting Rights and Shares
17 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah Raises $3 Million from its At-the-Market Equity Offering
13 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Nyxoah Raises $3 Million from an At-the-Market Equity Offering
27 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Nyxoah Announces a $15 Million Private Placement Financing
23 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
22 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
08 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference
07 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
-
Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
06 Mar 2023 01:30:00 By Nasdaq GlobeNewswire
-
Nyxoah Announces Inaugural Investor & Analyst Meeting
22 Feb 2023 06:00:00 By Nasdaq GlobeNewswire